Infusion Pumps and Accessories Market worth $9,427 Million by 2018

Thursday 17 April 2014, Amsterdam

The “Infusion Pumps and Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management), by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report studies the global infusion pumps and accessories market, with forecast to 2018.

The infusion pumps and accessories market has experienced moderate growth in the past few years. Factors that are expected to boost the market growth include the rising demand for disease management devices for the increasing number of patients with chronic diseases and the enhanced use of infusion devices in the home care segment. However, safety issues arising from the errors associated with the use of infusion pumps and stringent regulatory requirements for the development of new products may restrain the growth of infusion pumps and accessories market to a certain extent.

The global infusion pumps and accessories market is segmented by product type, application, end user, and geography. It also discusses the key market drivers, restraints, and opportunities of this market and its submarkets. The market was valued at $7,143 million in 2013 and is expected to grow at a CAGR of 5.7% from 2013 to 2018.

North America was a major market for infusion pumps and accessories with a market share of 40-45% of the global market in 2013, followed by Europe and the Asia-Pacific region. The government initiatives for better healthcare system and increasing awareness about healthcare in the developing economies will offer significant growth potential for the infusion pumps and accessories market in these regions.

The prominent companies in the market are B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), CareFusion Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Hospira, Inc. (U.S.), Smiths Medical (U.S.), and Terumo Corporation (Japan).